SYVC vs REGN: Which Stock is Better?

Side-by-side comparison of Synovics Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

SYVC

Synovics Pharmaceuticals Inc

$0.00

REGN

Regeneron Pharmaceuticals Inc

$746.00

Key Metrics Comparison

MetricSYVCREGNWinner
Market Cap$0.54M$79.71BREGN
P/E RatioN/A18.18REGN
EPS (TTM)$N/A$41.47REGN
Revenue Growth-0.8%0.0%REGN
Gross Margin23.4%44.6%REGN

Analyze SYVC

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SYVC or REGN a better investment?

Comparing SYVC and REGN: Synovics Pharmaceuticals Inc has a market cap of $0.54M while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SYVC and REGN?

SYVC (Synovics Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SYVC or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: SYVC or REGN?

REGN has higher revenue growth at 0.0% vs -0.8% for SYVC.

Which company is more profitable: SYVC or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 23.4% for SYVC.

Which is the larger company: SYVC or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $0.54M for SYVC.

Should I buy SYVC or REGN in 2026?

Both SYVC and REGN have investment merit. SYVC trades at $0.00 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SYVC and REGN stock?

Key differences: Market Cap ($0.54M vs $79.71B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (23.4% vs 44.6%).

Popular Stock Comparisons